{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T03:49:33Z","timestamp":1772768973919,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.mayocp.2020.02.026","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T22:09:04Z","timestamp":1596665344000},"page":"1928-1939","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Hospitalization With Major Infection and Incidence of End-Stage Renal Disease: The Atherosclerosis Risk in Communities (ARIC) Study"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6396-3723","authenticated-orcid":false,"given":"Junichi","family":"Ishigami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Logan T.","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan T.","family":"Demmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4430-6023","authenticated-orcid":false,"given":"Morgan E.","family":"Grams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela L.","family":"Lutsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Coresh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7179-718X","authenticated-orcid":false,"given":"Kunihiro","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3 suppl 1","key":"10.1016\/j.mayocp.2020.02.026_bib1","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2016.12.004","article-title":"US Renal Data System 2016 Annual Data Report: epidemiology of kidney disease in the United States [erratum in Am J Kidney Dis. 2017;69(5):712]","volume":"69","author":"Saran","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"suppl 7","key":"10.1016\/j.mayocp.2020.02.026_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/ndt\/16.suppl_7.57","article-title":"Identification of patients and risk factors in chronic kidney disease--evaluating risk factors and therapeutic strategies","volume":"16","author":"Levin","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.mayocp.2020.02.026_bib3","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1038\/ki.2010.418","article-title":"Mechanistic connection between inflammation and fibrosis","volume":"119","author":"Lee","year":"2010","journal-title":"Kidney Int Suppl"},{"issue":"4","key":"10.1016\/j.mayocp.2020.02.026_bib4","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1159\/000142934","article-title":"Inflammation in acute kidney injury","volume":"109","author":"Kinsey","year":"2008","journal-title":"Nephron Exp Nephrol"},{"key":"10.1016\/j.mayocp.2020.02.026_bib5","doi-asserted-by":"crossref","first-page":"137072","DOI":"10.1155\/2009\/137072","article-title":"Mediators of inflammation in acute kidney injury","volume":"2009","author":"Akcay","year":"2009","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.mayocp.2020.02.026_bib6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.pathol.1.110304.100100","article-title":"Inflammation and atherosclerosis","volume":"1","author":"Hansson","year":"2006","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.mayocp.2020.02.026_bib7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40560-016-0148-1","article-title":"Sepsis-induced myocardial dysfunction: pathophysiology and management","volume":"4","author":"Kakihana","year":"2016","journal-title":"J\u00a0Intensive Care"},{"issue":"suppl 3","key":"10.1016\/j.mayocp.2020.02.026_bib8","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/cc4829","article-title":"Hemodynamic optimization of sepsis-induced tissue hypoperfusion","volume":"10","author":"Zanotti Cavazzoni","year":"2006","journal-title":"Crit Care"},{"issue":"1-2","key":"10.1016\/j.mayocp.2020.02.026_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cccn.2004.09.005","article-title":"Drug-induced renal failure: a focus on tubulointerstitial disease","volume":"351","author":"Markowitz","year":"2005","journal-title":"Clin Chim Acta"},{"issue":"1","key":"10.1016\/j.mayocp.2020.02.026_bib10","first-page":"1","article-title":"KDIGO clinical practice guideline for acute kidney injury","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"issue":"3","key":"10.1016\/j.mayocp.2020.02.026_bib11","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/ki.2012.406","article-title":"The relevance of congestion in the cardio-renal syndrome","volume":"83","author":"Gnanara","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.mayocp.2020.02.026_bib12","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2147\/CLEP.S169039","article-title":"Hospital admission with pneumonia and subsequent persistent risk of chronic kidney disease: national cohort study","volume":"10","author":"Sundin","year":"2018","journal-title":"Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.mayocp.2020.02.026_bib13","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.kint.2016.07.013","article-title":"Infection in advanced chronic kidney disease leads to increased risk of cardiovascular events, end-stage kidney disease and mortality","volume":"90","author":"Cheikh Hassan","year":"2016","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.mayocp.2020.02.026_bib14","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/ki.2014.79","article-title":"Pneumococcal pneumonia infection is associated with end-stage renal disease in adult hospitalized patients","volume":"86","author":"Huang","year":"2014","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.mayocp.2020.02.026_bib15","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/oxfordjournals.aje.a115184","article-title":"The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators","volume":"129","year":"1989","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.mayocp.2020.02.026_bib16","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.ajkd.2016.09.018","article-title":"CKD and risk for hospitalization with infection: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"69","author":"Ishigami","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.mayocp.2020.02.026_bib17","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2215\/CJN.00250117","article-title":"eGFR and the risk of community-acquired infections","volume":"12","author":"Xu","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.mayocp.2020.02.026_bib18","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10157-018-1641-8","article-title":"Clinical epidemiology of infectious disease among patients with chronic kidney disease","volume":"23","author":"Ishigami","year":"2019","journal-title":"Clin Exp Nephrol"},{"issue":"24","key":"10.1016\/j.mayocp.2020.02.026_bib19","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1001\/jama.2014.6634","article-title":"Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality","volume":"311","author":"Coresh","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.mayocp.2020.02.026_bib20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1523-1755.2005.00080.x","article-title":"Relationship between hepatitis C and microalbuminuria: results from the NHANES III","volume":"67","author":"Liangpunsakul","year":"2005","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.mayocp.2020.02.026_bib21","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ki.2012.111","article-title":"HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics","volume":"82","author":"Atta","year":"2012","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.mayocp.2020.02.026_bib22","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1086\/605562","article-title":"Infectious disease hospitalizations in the United States","volume":"49","author":"Christensen","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.mayocp.2020.02.026_bib23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.mayocp.2020.02.026_bib24","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/CIRCULATIONAHA.113.008506","article-title":"Temporal trends in the population attributable risk for cardiovascular disease: the Atherosclerosis Risk in Communities Study","volume":"130","author":"Cheng","year":"2014","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.mayocp.2020.02.026_bib25","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1161\/STROKEAHA.116.012890","article-title":"Hospitalized infection as a trigger for acute ischemic stroke: the Atherosclerosis Risk in Communities Study","volume":"47","author":"Cowan","year":"2016","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.mayocp.2020.02.026_bib26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrneph.2013.250","article-title":"Cardiorenal syndrome--current understanding and future perspectives","volume":"10","author":"Braam","year":"2014","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1016\/j.mayocp.2020.02.026_bib27","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1681\/ASN.2019060574","article-title":"Incident hospitalization with major cardiovascular diseases and subsequent risk of ESKD: implications for cardiorenal syndrome","volume":"31","author":"Ishigami","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.mayocp.2020.02.026_bib29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/oxfordjournals.aje.a115471","article-title":"Nested case-control and case-cohort methods of sampling from a cohort: a critical comparison","volume":"131","author":"Langholz","year":"1990","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.mayocp.2020.02.026_bib30","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/S0002-9440(10)64683-4","article-title":"Murine gammaherpesvirus-68 infection causes multi-organ fibrosis and alters leukocyte trafficking in interferon-gamma receptor knockout mice","volume":"158","author":"Ebrahimi","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.mayocp.2020.02.026_bib31","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1146\/annurev.micro.57.030502.091033","article-title":"The secret lives of the pathogenic mycobacteria","volume":"57","author":"Cosma","year":"2003","journal-title":"Annu Rev Microbiol"},{"issue":"5","key":"10.1016\/j.mayocp.2020.02.026_bib32","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1172\/JCI117562","article-title":"Microvascular perfusion is impaired in a rat model of normotensive sepsis","volume":"94","author":"Lam","year":"1994","journal-title":"J\u00a0Clin Invest"},{"issue":"18","key":"10.1016\/j.mayocp.2020.02.026_bib33","doi-asserted-by":"crossref","first-page":"8264","DOI":"10.1073\/pnas.92.18.8264","article-title":"Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E","volume":"92","author":"Smith","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.mayocp.2020.02.026_bib34","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1172\/JCI11871","article-title":"A\u00a0major role for VCAM-1, but not ICAM-1, in early atherosclerosis","volume":"107","author":"Cybulsky","year":"2001","journal-title":"J\u00a0Clin Invest"},{"issue":"7","key":"10.1016\/j.mayocp.2020.02.026_bib35","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.autrev.2010.12.006","article-title":"Inflammation as \"common soil\" of the multifactorial diseases","volume":"10","author":"Scrivo","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.mayocp.2020.02.026_bib36","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/ki.2011.379","article-title":"Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis","volume":"81","author":"Coca","year":"2012","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.mayocp.2020.02.026_bib37","doi-asserted-by":"crossref","first-page":"682","DOI":"10.2215\/CJN.07650713","article-title":"Performance and limitations of administrative data in the identification of AKI","volume":"9","author":"Grams","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.mayocp.2020.02.026_bib38","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"issue":"5","key":"10.1016\/j.mayocp.2020.02.026_bib39","doi-asserted-by":"crossref","first-page":"115","DOI":"10.15585\/mmwr.mm6805a5","article-title":"Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older - United States, 2019","volume":"68","author":"Kim","year":"2019","journal-title":"MMWR Morbid Mortal Wkly Rep"},{"key":"10.1016\/j.mayocp.2020.02.026_bib40","author":"Ishigami"},{"issue":"1","key":"10.1016\/j.mayocp.2020.02.026_bib41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1053\/j.ajkd.2019.01.025","article-title":"Cost-effectiveness of pneumococcal vaccination among patients with CKD in the United States","volume":"74","author":"Ishigami","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1016\/j.mayocp.2020.02.026_bib42","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/acr.21959","article-title":"Systematic review of validation studies of the use of administrative data to identify serious\u00a0infections","volume":"65","author":"Barber","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.mayocp.2020.02.026_bib43","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.annepidem.2013.02.005","article-title":"Accuracy of ICD-9-CM codes in identifying infections of pneumonia and herpes simplex virus in administrative data","volume":"23","author":"Drahos","year":"2013","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.mayocp.2020.02.026_bib44","author":"Hall"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619620302093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619620302093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:33:11Z","timestamp":1758418391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619620302093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0025619620302093"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2020.02.026","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hospitalization With Major Infection and Incidence of End-Stage Renal Disease: The Atherosclerosis Risk in Communities (ARIC) Study","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2020.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}